关注
Shintaro Kuroda
Shintaro Kuroda
在 hiroshima-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery
H Tashiro, S Kuroda, Y Mikuriya, H Ohdan
Surgery today 44, 1611-1625, 2014
962014
Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study
M Hamaoka, T Kobayashi, S Kuroda, H Iwako, S Okimoto, T Kimura, ...
International Journal of Surgery 44, 223-228, 2017
652017
Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases
M Shimomura, T Hinoi, S Kuroda, T Adachi, Y Kawaguchi, T Sasada, ...
Annals of surgical oncology 20, 527-536, 2013
522013
No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy
S Kuroda, H Tashiro, T Kobayashi, A Oshita, H Amano, H Ohdan
World journal of surgery 36, 651-658, 2012
512012
A multicenter, randomized, controlled trial comparing reinforced staplers with bare staplers during distal pancreatectomy (HiSCO-07 Trial)
N Kondo, K Uemura, N Nakagawa, K Okada, S Kuroda, T Sudo, ...
Annals of surgical oncology 26, 1519-1527, 2019
482019
Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection
Y Tanimoto, H Tashiro, H Aikata, H Amano, A Oshita, T Kobayashi, ...
Annals of surgical oncology 19, 418-425, 2012
462012
Rho inhibitor prevents ischemia–reperfusion injury in rat steatotic liver
S Kuroda, H Tashiro, Y Igarashi, Y Tanimoto, J Nambu, A Oshita, ...
Journal of hepatology 56 (1), 146-152, 2012
462012
3D printing model of the intrahepatic vessels for navigation during anatomical resection of hepatocellular carcinoma
S Kuroda, T Kobayashi, H Ohdan
International journal of surgery case reports 41, 219-222, 2017
392017
Fatty liver creates a pro‐metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells
Y Mikuriya, H Tashiro, S Kuroda, J Nambu, T Kobayashi, H Amano, ...
International journal of cancer 136 (4), E3-E13, 2015
392015
Glasgow prognostic score and prognosis after hepatectomy for hepatocellular carcinoma
T Abe, H Tashiro, T Kobayashi, M Hattori, S Kuroda, H Ohdan
World journal of surgery 41 (7), 1860-1870, 2017
342017
Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: a propensity-matched analysis in a single institution
R Nakano, M Ohira, T Kobayashi, K Ide, H Tahara, S Kuroda, S Shimizu, ...
Surgery 164 (2), 219-226, 2018
332018
Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child‐Pugh class B
S Kuroda, H Tashiro, T Kobayashi, A Oshita, H Amano, H Ohdan
World journal of surgery 35 (4), 834-841, 2011
332011
Rho‐kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats
S Kuroda, H Tashiro, Y Kimura, K Hirata, M Tsutada, Y Mikuriya, ...
Liver Transplantation 21 (1), 123-131, 2015
322015
Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria
H Amano, H Tashiro, A Oshita, T Kobayashi, Y Tanimoto, S Kuroda, ...
Journal of Gastrointestinal Surgery 15 (7), 1173-1181, 2011
312011
Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog
Y Ushitora, H Tashiro, T Ogawa, Y Tanimoto, S Kuroda, T Kobayashi, ...
Transplantation 88 (8), 980-986, 2009
312009
Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection
H Tashiro, H Aikata, K Waki, H Amano, A Oshita, T Kobayashi, Y Tanimoto, ...
Journal of Surgical Oncology 104 (1), 3-9, 2011
302011
Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more
M Hamaoka, T Kobayashi, K Ishiyama, M Ohira, H Tahara, S Kuroda, ...
Journal of Hepato‐Biliary‐Pancreatic Sciences 24 (1), 58-64, 2017
262017
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
M Yamamoto, T Kobayashi, S Kuroda, M Hamaoka, S Okimoto, ...
Annals of Gastroenterological Surgery 3 (6), 667-675, 2019
252019
Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis
S Okimoto, T Kobayashi, H Tashiro, S Kuroda, K Ishiyama, K Ide, T Abe, ...
International Journal of Surgery 42, 209-214, 2017
232017
Prediction of long‐term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation
T Abe, H Tashiro, M Hattori, S Kuroda, H Tahara, M Ohira, T Kobayashi, ...
Hepatology Research 46 (7), 622-633, 2016
232016
系统目前无法执行此操作,请稍后再试。
文章 1–20